Cystatin C as a p53-inducible apoptotic mediator that regulates cathepsin L activity

Area of Science:

• Molecular Biology
• Cancer Research
• Biochemistry

Background:

• The tumor suppressor p53 protein is a critical regulator of cellular responses to stress.
• p53 exerts its tumor-suppressive functions by controlling the expression of target genes.
• The complete downstream signaling network of p53 remains incompletely understood.

Purpose of the Study:

• To identify novel p53 target genes involved in tumor suppression.
• To investigate the role of cystatin C in the p53 pathway.
• To explore the clinical relevance of the p53-cystatin C axis in breast cancer.

Main Methods:

• Identification of cystatin C as a p53 target gene.
• Analysis of p53 binding sequences in the cystatin C gene promoter.
• Assessment of cathepsin L activity in p53-proficient and deficient cells.
• Evaluation of cystatin C expression in breast cancer patient cohorts.

Main Results:

• Activated p53 directly induces cystatin C expression via a binding site in its first intron.
• DNA damage reduces cathepsin L activity in a p53-dependent manner.
• Knockdown of cystatin C impairs adriamycin-induced apoptosis.
• Downregulated cystatin C and p53 mutations correlate with poor breast cancer prognosis.

Conclusions:

• Cystatin C is a novel transcriptional target of p53.
• The p53-cystatin C pathway plays a significant role in inhibiting malignant transformation.
• Cystatin C represents a potential biomarker for breast cancer prognosis.